[1] Reiner, J., Berlin, P., Held, J., Thiery, J., Skarbaliene, J., Griffin, J., Russell, W., Eriksson, P.-O., Berner-Hansen, M., Ehlers, L., Vollmar, B., Jaster, R., Witte, M., Lamprecht, G. (2022). Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel.
Journal of Parenteral and Enteral Nutrition,
46 5, 1107–1118.
https://doi.org/10.1002/jpen.2286